Sexually Transmitted Diseases Diagnostics Market Size, Trends, Analysis, and Outlook By Disease (CT/NG, Gonorrhea, HIV/AIDS, Genital Herpes, Hepatitis B, Syphilis, Mycoplasma Genitalium, Genital Warts, Candidal Vaginitis, Trichomoniasis, Bacterial Vaginosis, HPV, Others), By Test (Culture/Isolation Of Organisms, Molecular Test, Immunology Assay, Others), By Device (Laboratory Devices, Point Of Care (Poc) Devices), By End-User (Laboratory, Point of Care (POC)), by Country, Segment, and Companies, 2024-2032
The global Sexually Transmitted Diseases Diagnostics market size is poised to register 6.1% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Sexually Transmitted Diseases Diagnostics market across By Disease (CT/NG, Gonorrhea, HIV/AIDS, Genital Herpes, Hepatitis B, Syphilis, Mycoplasma Genitalium, Genital Warts, Candidal Vaginitis, Trichomoniasis, Bacterial Vaginosis, HPV, Others), By Test (Culture/Isolation Of Organisms, Molecular Test, Immunology Assay, Others), By Device (Laboratory Devices, Point Of Care (Poc) Devices), By End-User (Laboratory, Point of Care (POC))
The sexually transmitted diseases (STDs) diagnostics market is influenced by the global burden of sexually transmitted infections, rising incidence of antibiotic resistance, and increasing adoption of molecular testing, point-of-care diagnostics, and multiplexed assays for rapid and accurate detection of STD pathogens. With a growing emphasis on prevention, early detection, and treatment of STDs, there's a demand for innovative diagnostic technologies offering high sensitivity, specificity, and usability in diverse clinical and non-clinical settings. By 2030, the market is expected to witness expanded applications in community screening, partner notification, and surveillance programs, alongside advancements in test performance, affordability, and accessibility, enabling timely intervention and reducing the transmission of STDs.
Sexually Transmitted Diseases Diagnostics Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Sexually Transmitted Diseases Diagnostics market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Sexually Transmitted Diseases Diagnostics survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Sexually Transmitted Diseases Diagnostics industry.
Key market trends defining the global Sexually Transmitted Diseases Diagnostics demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Sexually Transmitted Diseases Diagnostics Market Segmentation- Industry Share, Market Size, and Outlook to 2032
The Sexually Transmitted Diseases Diagnostics industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Sexually Transmitted Diseases Diagnostics companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Sexually Transmitted Diseases Diagnostics industry
Leading Sexually Transmitted Diseases Diagnostics companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Sexually Transmitted Diseases Diagnostics companies.
Sexually Transmitted Diseases Diagnostics Market Study- Strategic Analysis Review
The Sexually Transmitted Diseases Diagnostics market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
The Sexually Transmitted Diseases Diagnostics industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2032 in three case scenarios- low case, reference case, and high case scenarios.
Sexually Transmitted Diseases Diagnostics Country Analysis and Revenue Outlook to 2032
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2032. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2032.
North America Sexually Transmitted Diseases Diagnostics Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong healthcare infrastructure. Leading companies focus on new product launches in the changing environment. The US healthcare expenditure is expected to grow to $4.8 trillion in 2024 (around 3.7% growth in 2024), potentially driving demand for various Sexually Transmitted Diseases Diagnostics market segments. Similarly, Strong market demand is encouraging Canadian Sexually Transmitted Diseases Diagnostics companies to invest in niche segments. Further, as Mexico continues to strengthen its relations and invest in technological advancements, the Mexico Sexually Transmitted Diseases Diagnostics market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Sexually Transmitted Diseases Diagnostics Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Sexually Transmitted Diseases Diagnostics industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of vendors in identifying and leveraging new growth prospects positions the European Sexually Transmitted Diseases Diagnostics market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Sexually Transmitted Diseases Diagnostics Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Sexually Transmitted Diseases Diagnostics in Asia Pacific. In particular, China, India, and South East Asian Sexually Transmitted Diseases Diagnostics markets present a compelling outlook for 2032, acting as a magnet for both domestic and multinational vendors seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major countries in the APAC region.
Latin America Sexually Transmitted Diseases Diagnostics Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Sexually Transmitted Diseases Diagnostics Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Sexually Transmitted Diseases Diagnostics market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Sexually Transmitted Diseases Diagnostics.
Sexually Transmitted Diseases Diagnostics Market Company Profiles
The global Sexually Transmitted Diseases Diagnostics market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Abbott Laboratories, bioMйrieux SA, Bi-Rad Laboratories Inc, Danaher Corp, DiaSorin S.p.A, F. Hoffmann-La Roche Ltd, Grifols S.A., Hologic Inc, QIAGEN NV, Quidel Corp, Thermo Fisher Scientific Inc.
Recent Sexually Transmitted Diseases Diagnostics Market Developments
The global Sexually Transmitted Diseases Diagnostics market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Sexually Transmitted Diseases Diagnostics Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2032 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
By Disease
CT/NG
Gonorrhea
HIV/AIDS
Genital Herpes
Hepatitis B
Syphilis
Mycoplasma Genitalium
Genital Warts
Candidal Vaginitis
Trichomoniasis
Bacterial Vaginosis
HPV
Others
By Test
Culture/Isolation Of Organisms
Molecular Test
Immunology Assay
Others
By Device
Laboratory Devices
-Thermal Cyclers – PCR
-Lateral Flow Readers
-Flow Cytometers
-Absorbance Microplate Reader
-Differential Light Scattering Machines
Point Of Care (Poc) Devices
-Phone Chips (Microfluidics + ICT)
-Portable/Bench Top/Rapid Diagnostic Kits
By End-User
Laboratory
-Commerical/Private Labs
-Public Health Labs
Point of Care (POC)
Geographical Segmentation:
Abbott Laboratories
bioMйrieux SA
Bi-Rad Laboratories Inc
Danaher Corp
DiaSorin S.p.A
F. Hoffmann-La Roche Ltd
Grifols S.A.
Hologic Inc
QIAGEN NV
Quidel Corp
Thermo Fisher Scientific Inc
Formats Available: Excel, PDF, and PPT
The sexually transmitted diseases (STDs) diagnostics market is influenced by the global burden of sexually transmitted infections, rising incidence of antibiotic resistance, and increasing adoption of molecular testing, point-of-care diagnostics, and multiplexed assays for rapid and accurate detection of STD pathogens. With a growing emphasis on prevention, early detection, and treatment of STDs, there's a demand for innovative diagnostic technologies offering high sensitivity, specificity, and usability in diverse clinical and non-clinical settings. By 2030, the market is expected to witness expanded applications in community screening, partner notification, and surveillance programs, alongside advancements in test performance, affordability, and accessibility, enabling timely intervention and reducing the transmission of STDs.
Sexually Transmitted Diseases Diagnostics Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Sexually Transmitted Diseases Diagnostics market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Sexually Transmitted Diseases Diagnostics survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Sexually Transmitted Diseases Diagnostics industry.
Key market trends defining the global Sexually Transmitted Diseases Diagnostics demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Sexually Transmitted Diseases Diagnostics Market Segmentation- Industry Share, Market Size, and Outlook to 2032
The Sexually Transmitted Diseases Diagnostics industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Sexually Transmitted Diseases Diagnostics companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Sexually Transmitted Diseases Diagnostics industry
Leading Sexually Transmitted Diseases Diagnostics companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Sexually Transmitted Diseases Diagnostics companies.
Sexually Transmitted Diseases Diagnostics Market Study- Strategic Analysis Review
The Sexually Transmitted Diseases Diagnostics market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
- Industry Dynamics: Porter's Five Forces analysis to understand bargaining power, competitive rivalry, and threats that impact long-term strategy formulation.
- Strategic Insights: Provides valuable perspectives on key players and their approaches based on comprehensive strategy analysis.
- Internal Strengths and Weaknesses: Develop targeted strategies to leverage strengths, address weaknesses, and capitalize on market opportunities.
- Future Possibilities: Prepare for diverse outcomes with in-depth scenario analysis. Explore potential market disruptions, technology advancements, and economic changes.
The Sexually Transmitted Diseases Diagnostics industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2032 in three case scenarios- low case, reference case, and high case scenarios.
Sexually Transmitted Diseases Diagnostics Country Analysis and Revenue Outlook to 2032
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2032. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2032.
North America Sexually Transmitted Diseases Diagnostics Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong healthcare infrastructure. Leading companies focus on new product launches in the changing environment. The US healthcare expenditure is expected to grow to $4.8 trillion in 2024 (around 3.7% growth in 2024), potentially driving demand for various Sexually Transmitted Diseases Diagnostics market segments. Similarly, Strong market demand is encouraging Canadian Sexually Transmitted Diseases Diagnostics companies to invest in niche segments. Further, as Mexico continues to strengthen its relations and invest in technological advancements, the Mexico Sexually Transmitted Diseases Diagnostics market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Sexually Transmitted Diseases Diagnostics Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Sexually Transmitted Diseases Diagnostics industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of vendors in identifying and leveraging new growth prospects positions the European Sexually Transmitted Diseases Diagnostics market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Sexually Transmitted Diseases Diagnostics Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Sexually Transmitted Diseases Diagnostics in Asia Pacific. In particular, China, India, and South East Asian Sexually Transmitted Diseases Diagnostics markets present a compelling outlook for 2032, acting as a magnet for both domestic and multinational vendors seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major countries in the APAC region.
Latin America Sexually Transmitted Diseases Diagnostics Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Sexually Transmitted Diseases Diagnostics Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Sexually Transmitted Diseases Diagnostics market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Sexually Transmitted Diseases Diagnostics.
Sexually Transmitted Diseases Diagnostics Market Company Profiles
The global Sexually Transmitted Diseases Diagnostics market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Abbott Laboratories, bioMйrieux SA, Bi-Rad Laboratories Inc, Danaher Corp, DiaSorin S.p.A, F. Hoffmann-La Roche Ltd, Grifols S.A., Hologic Inc, QIAGEN NV, Quidel Corp, Thermo Fisher Scientific Inc.
Recent Sexually Transmitted Diseases Diagnostics Market Developments
The global Sexually Transmitted Diseases Diagnostics market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Sexually Transmitted Diseases Diagnostics Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2032 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
- Pricing Analysis
- Value Chain Analysis
- SWOT Profile
- Market Dynamics- Trends, Drivers, Challenges
- Porter’s Five Forces Analysis
- Macroeconomic Impact Analysis
- Case Scenarios- Low, Base, High
By Disease
CT/NG
Gonorrhea
HIV/AIDS
Genital Herpes
Hepatitis B
Syphilis
Mycoplasma Genitalium
Genital Warts
Candidal Vaginitis
Trichomoniasis
Bacterial Vaginosis
HPV
Others
By Test
Culture/Isolation Of Organisms
Molecular Test
Immunology Assay
Others
By Device
Laboratory Devices
-Thermal Cyclers – PCR
-Lateral Flow Readers
-Flow Cytometers
-Absorbance Microplate Reader
-Differential Light Scattering Machines
Point Of Care (Poc) Devices
-Phone Chips (Microfluidics + ICT)
-Portable/Bench Top/Rapid Diagnostic Kits
By End-User
Laboratory
-Commerical/Private Labs
-Public Health Labs
Point of Care (POC)
Geographical Segmentation:
- North America (3 markets)
- Europe (6 markets)
- Asia Pacific (6 markets)
- Latin America (3 markets)
- Middle East Africa (5 markets)
Abbott Laboratories
bioMйrieux SA
Bi-Rad Laboratories Inc
Danaher Corp
DiaSorin S.p.A
F. Hoffmann-La Roche Ltd
Grifols S.A.
Hologic Inc
QIAGEN NV
Quidel Corp
Thermo Fisher Scientific Inc
Formats Available: Excel, PDF, and PPT
1. EXECUTIVE SUMMARY
1.1 Sexually Transmitted Diseases Diagnostics Market Overview and Key Findings, 2024
1.2 Sexually Transmitted Diseases Diagnostics Market Size and Growth Outlook, 2021- 2030
1.3 Sexually Transmitted Diseases Diagnostics Market Growth Opportunities to 2030
1.4 Key Sexually Transmitted Diseases Diagnostics Market Trends and Challenges
1.4.1 Sexually Transmitted Diseases Diagnostics Market Drivers and Trends
1.4.2 Sexually Transmitted Diseases Diagnostics Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Sexually Transmitted Diseases Diagnostics Companies
2. SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE OUTLOOK TO 2030
2.1 Sexually Transmitted Diseases Diagnostics Market Size Outlook, USD Million, 2021- 2030
2.2 Sexually Transmitted Diseases Diagnostics Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Disease
CT/NG
Gonorrhea
HIV/AIDS
Genital Herpes
Hepatitis B
Syphilis
Mycoplasma Genitalium
Genital Warts
Candidal Vaginitis
Trichomoniasis
Bacterial Vaginosis
HPV
Others
By Test
Culture/Isolation Of Organisms
Molecular Test
Immunology Assay
Others
By Device
Laboratory Devices
-Thermal Cyclers – PCR
-Lateral Flow Readers
-Flow Cytometers
-Absorbance Microplate Reader
-Differential Light Scattering Machines
Point Of Care (Poc) Devices
-Phone Chips (Microfluidics + ICT)
-Portable/Bench Top/Rapid Diagnostic Kits
By End-User
Laboratory
-Commerical/Private Labs
-Public Health Labs
Point of Care (POC)
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Sexually Transmitted Diseases Diagnostics Market, 2025
5.2 Asia Pacific Sexually Transmitted Diseases Diagnostics Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Sexually Transmitted Diseases Diagnostics Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Sexually Transmitted Diseases Diagnostics Market, 2025
5.5 Europe Sexually Transmitted Diseases Diagnostics Market Size Outlook by Type, 2021- 2030
5.6 Europe Sexually Transmitted Diseases Diagnostics Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Sexually Transmitted Diseases Diagnostics Market, 2025
5.8 North America Sexually Transmitted Diseases Diagnostics Market Size Outlook by Type, 2021- 2030
5.9 North America Sexually Transmitted Diseases Diagnostics Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Sexually Transmitted Diseases Diagnostics Market, 2025
5.11 South America Pacific Sexually Transmitted Diseases Diagnostics Market Size Outlook by Type, 2021- 2030
5.12 South America Sexually Transmitted Diseases Diagnostics Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Sexually Transmitted Diseases Diagnostics Market, 2025
5.14 Middle East Africa Sexually Transmitted Diseases Diagnostics Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Sexually Transmitted Diseases Diagnostics Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Sexually Transmitted Diseases Diagnostics Market Size Outlook and Revenue Growth Forecasts
6.2 US Sexually Transmitted Diseases Diagnostics Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Sexually Transmitted Diseases Diagnostics Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Sexually Transmitted Diseases Diagnostics Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Sexually Transmitted Diseases Diagnostics Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Sexually Transmitted Diseases Diagnostics Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Sexually Transmitted Diseases Diagnostics Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Sexually Transmitted Diseases Diagnostics Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Sexually Transmitted Diseases Diagnostics Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Sexually Transmitted Diseases Diagnostics Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Sexually Transmitted Diseases Diagnostics Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Sexually Transmitted Diseases Diagnostics Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Sexually Transmitted Diseases Diagnostics Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Sexually Transmitted Diseases Diagnostics Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Sexually Transmitted Diseases Diagnostics Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Sexually Transmitted Diseases Diagnostics Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Sexually Transmitted Diseases Diagnostics Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Sexually Transmitted Diseases Diagnostics Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Sexually Transmitted Diseases Diagnostics Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Sexually Transmitted Diseases Diagnostics Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Sexually Transmitted Diseases Diagnostics Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Sexually Transmitted Diseases Diagnostics Industry Drivers and Opportunities
7. SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS COMPANY PROFILES
8.1 Profiles of Leading Sexually Transmitted Diseases Diagnostics Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Abbott Laboratories
bioMйrieux SA
Bi-Rad Laboratories Inc
Danaher Corp
DiaSorin S.p.A
F. Hoffmann-La Roche Ltd
Grifols S.A.
Hologic Inc
QIAGEN NV
Quidel Corp
Thermo Fisher Scientific Inc.
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
1.1 Sexually Transmitted Diseases Diagnostics Market Overview and Key Findings, 2024
1.2 Sexually Transmitted Diseases Diagnostics Market Size and Growth Outlook, 2021- 2030
1.3 Sexually Transmitted Diseases Diagnostics Market Growth Opportunities to 2030
1.4 Key Sexually Transmitted Diseases Diagnostics Market Trends and Challenges
1.4.1 Sexually Transmitted Diseases Diagnostics Market Drivers and Trends
1.4.2 Sexually Transmitted Diseases Diagnostics Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Sexually Transmitted Diseases Diagnostics Companies
2. SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE OUTLOOK TO 2030
2.1 Sexually Transmitted Diseases Diagnostics Market Size Outlook, USD Million, 2021- 2030
2.2 Sexually Transmitted Diseases Diagnostics Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Disease
CT/NG
Gonorrhea
HIV/AIDS
Genital Herpes
Hepatitis B
Syphilis
Mycoplasma Genitalium
Genital Warts
Candidal Vaginitis
Trichomoniasis
Bacterial Vaginosis
HPV
Others
By Test
Culture/Isolation Of Organisms
Molecular Test
Immunology Assay
Others
By Device
Laboratory Devices
-Thermal Cyclers – PCR
-Lateral Flow Readers
-Flow Cytometers
-Absorbance Microplate Reader
-Differential Light Scattering Machines
Point Of Care (Poc) Devices
-Phone Chips (Microfluidics + ICT)
-Portable/Bench Top/Rapid Diagnostic Kits
By End-User
Laboratory
-Commerical/Private Labs
-Public Health Labs
Point of Care (POC)
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Sexually Transmitted Diseases Diagnostics Market, 2025
5.2 Asia Pacific Sexually Transmitted Diseases Diagnostics Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Sexually Transmitted Diseases Diagnostics Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Sexually Transmitted Diseases Diagnostics Market, 2025
5.5 Europe Sexually Transmitted Diseases Diagnostics Market Size Outlook by Type, 2021- 2030
5.6 Europe Sexually Transmitted Diseases Diagnostics Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Sexually Transmitted Diseases Diagnostics Market, 2025
5.8 North America Sexually Transmitted Diseases Diagnostics Market Size Outlook by Type, 2021- 2030
5.9 North America Sexually Transmitted Diseases Diagnostics Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Sexually Transmitted Diseases Diagnostics Market, 2025
5.11 South America Pacific Sexually Transmitted Diseases Diagnostics Market Size Outlook by Type, 2021- 2030
5.12 South America Sexually Transmitted Diseases Diagnostics Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Sexually Transmitted Diseases Diagnostics Market, 2025
5.14 Middle East Africa Sexually Transmitted Diseases Diagnostics Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Sexually Transmitted Diseases Diagnostics Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Sexually Transmitted Diseases Diagnostics Market Size Outlook and Revenue Growth Forecasts
6.2 US Sexually Transmitted Diseases Diagnostics Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Sexually Transmitted Diseases Diagnostics Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Sexually Transmitted Diseases Diagnostics Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Sexually Transmitted Diseases Diagnostics Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Sexually Transmitted Diseases Diagnostics Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Sexually Transmitted Diseases Diagnostics Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Sexually Transmitted Diseases Diagnostics Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Sexually Transmitted Diseases Diagnostics Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Sexually Transmitted Diseases Diagnostics Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Sexually Transmitted Diseases Diagnostics Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Sexually Transmitted Diseases Diagnostics Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Sexually Transmitted Diseases Diagnostics Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Sexually Transmitted Diseases Diagnostics Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Sexually Transmitted Diseases Diagnostics Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Sexually Transmitted Diseases Diagnostics Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Sexually Transmitted Diseases Diagnostics Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Sexually Transmitted Diseases Diagnostics Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Sexually Transmitted Diseases Diagnostics Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Sexually Transmitted Diseases Diagnostics Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Sexually Transmitted Diseases Diagnostics Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Sexually Transmitted Diseases Diagnostics Industry Drivers and Opportunities
7. SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS COMPANY PROFILES
8.1 Profiles of Leading Sexually Transmitted Diseases Diagnostics Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Abbott Laboratories
bioMйrieux SA
Bi-Rad Laboratories Inc
Danaher Corp
DiaSorin S.p.A
F. Hoffmann-La Roche Ltd
Grifols S.A.
Hologic Inc
QIAGEN NV
Quidel Corp
Thermo Fisher Scientific Inc.
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
